Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens

Area of Science:

• Microbiology
• Pharmacology
• Ethnobotany

Background:

• Opportunistic bacterial pathogens, including Acinetobacter baumannii (a member of the ESKAPE group), contribute significantly to morbidity, mortality, and healthcare costs.
• Acinetobacter baumannii poses a growing clinical challenge due to its increasing prevalence and resistance to commonly prescribed antibiotics like carbapenems.
• The lack of effective pharmaceutical solutions necessitates the urgent search for alternative treatments against carbapenem-resistant Acinetobacter baumannii.

Purpose of the Study:

• To review plant-derived compounds with demonstrated antibacterial activity against Acinetobacter baumannii, including carbapenem-resistant strains.
• To highlight methods for the separation and identification of these active plant compounds.
• To provide a resource for researchers seeking novel antibacterial agents as carbapenem alternatives.

Main Methods:

• Literature review of scientific databases focusing on ethnobotany and pharmacology.
• Analysis of studies reporting antibacterial activity of plant extracts and isolated compounds against Acinetobacter baumannii.
• Summary of techniques used for phytochemical analysis and compound identification.

Main Results:

• Several plant compounds exhibit potent antibacterial activity against Acinetobacter baumannii, including carbapenem-resistant isolates.
• Established methods exist for the isolation and characterization of these bioactive phytochemicals.
• The review consolidates information on promising natural product candidates for further drug development.

Conclusions:

• Plant-derived compounds represent a viable avenue for developing new therapeutic strategies against Acinetobacter baumannii infections.
• Further research into the efficacy, safety, and mechanisms of action of these compounds is warranted.
• This review supports the exploration of ethnobotanical resources for novel antibacterial drug discovery.